Cardiovascular risks in type 2 diabetes and the interpretation of cardiovascular outcome trials
Deborah Hinnen,1 Davida F Kruger2 1Department of Health and Wellness, Memorial Hospital Diabetes Center, University of Colorado Health, Colorado Springs, CO 80909, USA; 2Henry Ford Health System, Division of Endocrinology, Diabetes, Bone and Mineral Disease, Henry Ford Medical Center – New...
Guardado en:
Autores principales: | Hinnen D, Kruger DF |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e201ad0b5d9b4b599fbfa9c4eab0843d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Relationship Between Skeletal Muscle Mass to Visceral Fat Area Ratio and Cardiovascular Risk in Type 2 Diabetes
por: Liu D, et al.
Publicado: (2021) -
Cardiovascular Safety and Superiority of Anti-Obesity Medications
por: Alobaida M, et al.
Publicado: (2021) -
Vascular Age as a Cardiovascular Risk Marker in Asymptomatic Patients with Type 2 Diabetes
por: Palma CCSSV, et al.
Publicado: (2020) -
Serum Ferritin Independently Predicts the Incidence of Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus
por: Wu YH, et al.
Publicado: (2020) -
Russian multicentre type 2 diabetes screening program in patients with cardiovascular disease
por: Marina Vladimirovna Shestakova, et al.
Publicado: (2016)